Изучение эндотелиопротективного действия ацетилизочистозида и его комбинации с эналаприлом
Диссертация
Учитывая возможные механизмы реализации предотвращения развития ЭД, следует отметить, что одними из перспективных групп для фармакологической коррекции ЭД являются флавоноидные соединения. Исследования, посвященные изучению ангиопротекторных и антиоксидантных свойств природных флавоноидов, в том числе и при диабетической микрои макроангиопатии, выявили, что флавоноиды обладают… Читать ещё >
Список литературы
- Автандилов, Г. Г. Основы патологоанатомической практики / Г. Г. Автандилов. М.: РМАПО, 1994. — 512с.
- Беленков, Ю.Н. Ингибиторы ангиотензин-превращающего фермента в лечении сердечно-сосудистых заболеваний (Квинаприл и эндотелиальная дисфункция) / Ю. Н. Беленков, В. Ю. Мареев, Ф. Т. Агеев. М.: ООО «Инсайт полиграфик», 2002. — 86 с.
- Белоусов, Ю.Б. Эндотелиальная дисфункция как причинаатеросклеротического поражения артерий при артериальной гипертензии: методы коррекции / Ю. Б. Белоусов, Ж. Н. Намсараев // Фарматека. 2000. — № 6. — С. 62−72.
- Галаган, М.Е. Гипотензивное действие оксида азота, продуцируемого из экзо-и эндогенных источников / М. Е. Галаган, А. В. Широколова, А. Ф. Ванин // Вопр. мед. химии.- 1991. Т. 37, № 1. — С. 67−70.
- Гогин, Е.Е. Природа артериальной гипертензии. Роль и м есто ингибиторов АПФ среди прочих антигипертензивных средств / Е. Е. Гогин // Фарматека. 2002. — № 2/3. — С. 14−23.
- Ковалев Г. В., Спасов A.A., Богачев H.A. и др. Бюлл. эксперим. биологии и медицины. 1987. — Т. 104, № 11. — с.588−590.
- Мазуров, В.И. Эндотелиальная дисфункция при метаболическом синдроме / В. И. Мазуров, В. А. Якушева В.А. // Эфферентная терапия.2006.-Т. 12. № 3. — С. 19−24.
- Маколкин, В.И. Артериальная гипертония фактор риска сердечнососудистых заболеваний / В. И. Маколкин // Рус. мед. журн. — 2002. — Т. 10, № 19.-С. 862−864.
- Маколкин, В.И. Новые возможности лечения сердечно-сосудистых заболеваний ингибиторами ангиотензинпревращающего фермента / В. И. Маколкин // Кардиоваскуляр. терапия и профилактика — 2005.- № 5- С. 66−70.
- Марков Х.М. Оксид азота в физиологии и патологии почек / Х. М. Марков // Вести РАМН. 1996. — № 7. — С. 73−78.
- Марков, Х.М. О регуляции деятельности сердца системой L-аргинин— оксид азота / Х. М. Марков, С. А. Надирашвили // Пат. физиол. экспер. тер. -2003.-№ 4. С. 9—11.
- Марков, Х.М. L-аргинин — оксид азота в терапии болезней сердца, и сосудов / Х. М. Марков // Кардиология. 2005. — С. 87—95.
- Марков, Х.М. NO и СО — новый класс сигнальных молекул / Х. М. Марков // Успехи физиол. наук. 1996. — Т. 27. — № 4. — С. 30 — 43.
- Марков, Х.М. Возрастные особенности коронарных эффектов оксида азота / Х. М. Марков, С. А. Надирашвили // Рос. педиатр, журн. 2004. -№ 4.-С. 17−21.
- Марков, Х.М. Молекулярные механизмы дисфункции сосудистого эндотелия / Х. М. Марков // Кардиология. 2005. — Т. 45, № 12. — С. 62−80.
- Марков, Х.М. О биорегуляторной системе L-аргинин-оксид азота / Х. М. Марков // Патол. физиол. экспер. тер. 1996. — № 1. — С. 34−39.
- Марков, Х. М. Оксид азота и сердечно-сосудистая система / Х. М. Марков // Успехи физиол. наук. 2001. — Т 32. — № 3. — С 49—65.
- Марков, Х.М. Простаноиды и атеросклероз / Х. М. Марков // Патологическая физиология. 2004. — № 1. -С. 2−8.
- Марков, Х.М. Роль оксида азота и патогенезе болезней детского возраста / Х. М. Марков // Рос. вести перинатол. и педиат. 2000. — № 4. — С.43— 47.
- Марков, Х.М. Сосудистые эффекты липопротеинов и оксид азота: клеточные и молекулярные механизмы / Х. М. Марков // Патологическая физиология и экспериментальная терапия. 2006. — № 3. -С. 2−7.
- Метельская, В. А. Возможности лабораторной оценки NO-продуцирующей функции эндотелия / /Клинич. и лаб. диагностика. -2004,-№ 9.-С. 86.
- Пашин, E.H. Кардиопротективное действие эмоксипина на модели гипоксия-реоксигенация / Е. Н. Пашин // Актуальные вопросы экспериментальной и клинической медицины и фармации: материалы конф. /КГМУ. Курск, 1993. — С. 171.
- Пичугин, В.В. Биохимические и функциональные аспекты экспериментальной терапии расстройств кровоснабжения и биоэнергетики миокарда в острой стадии регионарной ишемии сердца: автореф. дис. д-ра мед. наук / В. В. Пичугин. М., 1979. — 25 с.
- Покровский В.И., Виноградов Н. А. Оксид азота, его физиологические и патофизиологические свойства// Терапевтическийй архив. № 1. — 2005. -С. 82−87.
- Характеристика биохимических маркеров функции сосудистого эндотелия: разработка модельной системы с применением клеточных культур / В. А. Метельская, Н. Г. Туманова, О. А. Литинская и др. // Вопр. биол. медицины и фарм. химии. -2004. № 2. — С. 34−39.
- Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia / H. Masuda, M. Goto, S. Tamaoki, H. Azuma // Br. J. Pharmacol. 1999. — Vol. 126. — P. 211 218.
- Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia / H. Masuda, T. Tsujii, N. Okuno et al. // Am. J. Physiol. Regul. Integr. Сотр. Physiol. 2002. — Vol. 282. -P.1730−1738.
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure / P. Vallance, A. Leone, A. Calver et al. // Lancet. 1992. — Vol. 339.-P. 572−575.
- Acute brain cytokine responses after global birth hypoxia in the rat / H. Ashdown, S. Joita, G.N. Luheshi, P.J. Boksa //Neurosci. Res. 2008. — Jul 14.
- Agewall, S. Does a glass of red wine improve endothelial function?/ S. Agewall- S .^Wright, R.N. Doughty et al. // Eur. Heart. J. 2000. — N21. -P.74−78.
- Aging-associated endothelial dysfunction in humans is reserved by L-Arginine / A. Chauhan, R.S. More, P.A. Mullins et al. // J. Am. Coll. Cardiol. 1996. -Vol. 28.-P. 1796— 1804.
- Alderton, W. K. Nitric oxide synthases: structure, function and inhibition / W.K. Alderton, C.E. Cooper, R.G. Knowles // Biochem. J. 2001 — Vol. 357. -P. 593−615.
- Angiotensin induces inflammatory activation of human vascular smooth muscle cells / R. Kranzhofer, J. Schmidt, C.A. Pfeiffer et al. // Arterioscler. Thromb. Vase. Biol. 1999. — Vol. 19. — P. 1623−1629.
- Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography-mass spectrometry / D. Tsikas, I. Sandmann, A. Savva et al. // J. Chromatogr. B. Biomed. Sei. Appl. 2000. — Vol. — 742. — P. 143−145.
- Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese./ T. Nakayama, M. Soma, Y. Takahashi et al. //. Clin. Genet. 1997. — Vol. 51. — P. 26— 30.
- Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia / R.H. Boger, S.M. Bode-Boger, A. Szuba et al. // Circulation. 1998. — Vol. 98. — P. 1842— 1847.
- Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects / J.T. Kielstein, S.M. Bode-Boger, J.C. Frolich et al. // Circulation. -2003.-Vol. 107.-P. 1891−1895.
- Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease / C. Zoccali, F.A. Benedetto, R. Maas et al. // J. Am. Soc. Nephrol. 2002. — Vol. 13. — P. 490−496.
- Asymmetrical dimethylarginine (ADMA) in critically ill patients: High plasma ADMA concentration is an independent risk factor of ICU mortality / R.J. Nijveldt, T. Teerlink, B. Van Der Hoven et al. // Clin. Nutr. 2033. — Vol. 22. -P. 23−30.
- Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension / H. Matsuoka, S. Itoh, M. Kimoto et al. // Hypertension. 1997. — Vol. 29. — P. 242−247.
- Auger, J.M. Dynamic tyrosine kinase-regulated signaling and actin polymerisation mediate aggregate stability under shear / J.M. Auger, S.P. Watson // Arterioscler. Thromb. Vase. Biol. 2008. — Vol. 28. P. 1499−1504.
- Awtry, E.H. Aspirin. / E.N.Awtry, J. Loscalzo // Circulation. 2000. — Vol. -101. P.1206−1218.
- Barron, J.T. Energetic effects of adenosine on vascular smooth muscle / J.T. Barron, L. Gu // Am. J. Physiol. Heart. Circ. Physiol. 2000. — Vol. 278. — P. 26−32.
- Berk, B.C. Atheroprotective signaling mechanisms activated by steady laminar flow in endothelial cells / B.C. Berk // Circulation. 2008. — Vol. 117. — P. 1082−1089.
- Bian, K. Vascular system: role of nitric oxide in cardiovascular diseases / K. Bian, M.E. Doursout, F. Murad // J. Clin. Hypertens. (Greenwich). 2008. -Vol. 10.-P. 304−310.
- Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease / R.H. Boger, S.M. Bode-Boger, W. Thiela et al. // Circulation. 1997. — Vol. 95. — P. 2068— 2074.
- Boger, R.H. Is asymmetric dimethylarginine a novel marker of atherosclerosis? / R.H. Boger, S.M. Bode-Boger, H. Matsuoka et al. // Circulation. 2000. -Vol. 101.-P. 160—161.
- Brown, C.A. Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Health Study/
- C.A.Brown, C. Bolton-Smith, M. Woodward et al. // J Epidemiol Community Health. 1993.-Vol. 47.-P.171−175.
- Caveolin, caveolae, and endothelial cell function / P.G. Frank, S.E. Woodman,
- D.S. Park, M.P. Lisanti // Arterioscler. Thromb. Vase. Biol. 2003. — Vol. 23 -P. 1161 — 1168.
- Chien, S. Role of shear stress direction in endothelial mechanotransduction / S. Chien // Mol. Cell. Biochem. 2008. — Vol. 5. — P. 1−8.
- Chiu, J.J. Vascular endothelial responses to altered shear stress: Pathologic implications for atherosclerosis / J.J. Chiu, S. Usami, S. Chien // Ann. Med. -2008.-Vol. 18.-P. 1−10.
- Chou E.J. Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease / J.E.Chou, J.G.Keevil, S. Aeschlimann et al.// Am. J. Cardiol. 2001.-Vol.88.-P.553−555.
- Churchill, E.N. The roles of PKC delta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury / E.N. Churchill, D. Mochly-Rosen // Biochem. Soc. Trans. 2007. — Vol. 35. — P. 1040−1042.
- Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease / S. Xiao, L. Wagner, R.J. Schmidt, C. Bay lis // Kidney Int. 2001. — Vol. 59. — P. 1466−1472.I
- Cooke, J.P. A novel mechanism for pulmonary arterial hypertension? / J.P. Cooke//Circulation.-2003.-Vol. 108.-P. 1420—1421.
- Cooke, J.P. Does AJDMA cause endothelial dysfunction? // Arterioscler. Thromb. Vase. Biol. 2000. — Vol. 20. — P. 2032−2037.
- Cooke, J.P. Flow, NO and atherogenesis / J.P. Cooke // Proc. Nat. Acad. Sci. -2003. Vol.100. — P. 768−770.
- Coronary endothelial dysfunction after ischemia and reperfusion and its prevention by ischemic preconditioning / P. Pagliaro, A. Chiribiri, D. Mancardi e. al. // Ital. Heart J.- 2003.- Vol. 4. N 6. — P. 383−394.
- Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan / E.L. Schiffrin, J.B. Park, H.D. Intengan, R.M. Touyz // Circulation.- 2000. Vol. 101, N14. -P.1653−1659.
- Das, M. Molecular mechanism of preconditioning / M. Das, D.K. Das // IUBMB Life. 2008. — Vol. 60. — P. 199−203.
- Defective L-arginine nitric oxide pathway in offsping of essential hypertensive patients / S. Taddei, A. Virdis, P. Mattei el al. // Circulation. — 1996. — Vol. 94. P. 1296−1303.
- Demrow, H.S. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries / H.S. Demrow, P.R. Slane, J.F. Folts // Circulation. 1995. — Vol. 91. — P. l 182−1188.
- Devasenapathy, N. Remote ischaemic preconditioning / N. Devasenapathy, G. Karthikeyan // Lancet. 2007. — Vol. 370. — P. 9604.
- Development of «no-reflow» phenomenon in ischemia/reperfusion injury: failure of active vasomotility and not simply passive vasoconstriction / J.
- Nanobashvili, C. Neumayer, A. Fuegl et al. // Eur. Surg. Res. 2003. — Vol. 35. -P: 417−424.
- Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence / H. Dayoub, V. Achan, S. Adimoolam et al. // Circulation. 2003. — Vol. 108. — P. 3042−3047.
- Diminished NO release in chronic hypoxic human endothelial cells / L. Ostergaard, E. Stankevicius, M. R. Andersen et al. // Am. J. Physiol. Heart. Circ. Physiol. 2007. — Vol. 293. — P. 2894 — 2903.
- Duffy, S.J. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease/ S J. Duffy, J.F. Keaney Jr, M. Holbrook et al.// Circulation. 2001. — Vol.104. — P. 151−156.
- Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells / T. Osanai, M. Saitoh, S. Sasaki et al. // Hypertension. -2003. Vol. 42. — P. 985−990.
- Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats / V. De Gennaro Colonna, G. Rossoni, A. Rigamonti et al. // Eur. J. Pharmacol. 2002. — Vol. 450, N1. — P. 61−66.
- Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis / H. Miyazaki, H. Matsuoka, J.P. Cooke et al. // Circulation. 1999. — Vol. 99. -P. 1141−1146.
- EndoPDI, a Novel Protein-disulfide Isomerase-like Protein That Is Preferentially Expressed in Endothelial Cells Acts as a Stress Survival Factor /1.l
- D. C. Sullivan, L. Huminiecki, J. W. Mooreet al. // J. Biol. Chem. 2003. -Vol. 278,-R47079 — 47 088.
- Endothelial actin cytoskeleton remodeling during mechanostimulation with fluid shear stress / E.A. Osbom, A. Rabodzey, C. F Jr. Dewey, J.H. Hartwig // Am. J. Physiol. Cell. Physiol. 2006. — Vol. 290. — P. 444−452.
- Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide / G. Hasdan, S. Benchetrit, G. Rashid et al. // Kidney Int. 2002. — Vol. 61. — P. 586−590.
- Endothelial dysfunction in hypercholesterolemia is improved by L-arginine administration: Possible role of oxidative stress / H. Kawano, T. Motoyama, N. Hirai et al. // Atherosclerosis. 2002. — Vol. 161. P. 375−380.
- Endothelial dysfunction induced by hyperhomocyst (e)inemia: role of asymmetric dimethylarginine / M.C. Stuhlinger, R.K. Oka, E.E. Graf et al. // Circulation. -2003. Vol. 108. — P. 933−938.
- Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease / T. Heitzer, T. Schlinzig, K. Krohn et al. // Circulation. 2001. — Vol. 104. — P. 2673−2678.
- Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine /P.S. Tsao, L. McEnvoy, H. Drexler, et al. // Circulation. 1994. -Vol. 89.-P. 2176−2182.
- Erdman, J.W. Proceedings of the ILSI North America Flavonoids Workshop/J.W. Erdman, D. Balentine, L. Arab et al. // J. Flavonoids and Heart Health. May 31-June 1. — 2005. — Washington. — D.C. J. Nutr. — Vol. — 137. -P.718 -737.
- Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension / J. L. Millatt, G.S. Whitley, D. Li et al. // Circulation. 2003. — Vol. 108. — P. 1493— 1498.
- Expression of a functionally active gp91phox-containing neutrophil-type NAD (P)H oxidase in smooth muscle cells from human resistance arteries:
- Regulation by angiotensin II / R.M. Touyz, X. Chen, F. Tabet et al. I I Circ. Res. 2OO2TV0I. 90. — P. 1205−1213.
- Flow shear stress stimulates Gabl tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells / Z.G.Jin, C. Wong, J. Wu, B.C. Berk // J. Biol. Chem. 2005. — Vol. -280. — P. 12 305−12 309.
- Free radical production by dysfunctional eNOS / M.C. Verhaar, P.E. Westerweel, A.J. van Zanneveld, T.J. Rabelink // Heart. 2004. — Vol. 90. — P. 494−495.
- Freedman JE, Parker C III, Li L, et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 2001- 103:2792−8.
- Gao, R. Scutellarein inhibits hypoxia- and moderately-high glucose-induced proliferation and VEGF expression in human retinal endothelial cells / R. Gao, B.H. Zhu, S.B. Tang et al. // Acta Pharmacol Sin. 2008. — Vol. 29, № 6. — P. 707−712.
- Geleijnse, J.M. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study / J.M. Geleijnse, L.J. Launer, D.A. Van der Kuip, et al.// Am. J. Clin. Nutr. 2002. — Vol.75. — P.880−886.
- Glucocorticoid^ regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport / W.W. Simmons, D. Ungureanu-Longrois, K.G. Smth et al. // J. Biol. Chem. 1996. — Vol. 271 — P. 23 928−23 937.
- Glucocorticoids mediate the enhanced expression of intestinal type II arginase and argininosuccinate lyase in postweaning pigs / N.E. Flynn, C.J. Meininger, K. Kelly et al. // J. Nutr. 1999. — Vol. 129. -P. 799−803.
- Griendling, K. K. NAD (P)H oxidase: role in cardiovascular biology and disease / K.K. Griendling, D. Sorescu, M. Ushio-Fukai // Circ. Res. 2000. -Vol. 86.-P. 494−501.
- Griendling, K.K. Oxidative stress and cardiovascular injury: Part I: Basic mechanisms-and in vivo monitoring of ROS / K.K. Griendling, G.A. FitzGerald // Circulation. 2003. — Vol.108. — P. 1912−1916.
- Griffits, P.W. Nitric oxide synthases: properties and catalytic mechanism / P.W. Griffits, D.J. Stuehr // Ann. Rev. Physiol. 1995. — Vol.57. — P. 707— 736.
- Guoyao, W.U. Arginine metabolism: nitric oxide and beyond / W.U. Guoyao, S.M. Morris // Biochem. J. 1998. — Vol. 336. — P. 1−17.
- Heiss, C. Vascular effects of cocoa rich in flavan-3-ols / C. Heis, A. Dejam, P. Kleinbongard et al. //. JAMA. 2003. — Vol.290. -P.1030−1031.
- Hertog, M.G. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study / M.G. Hertog, P.M. Sweetnam, A.M. Fehily et al. //. Am. J. Clin. Nutr. 1997. — Vol. -65. -P. 1489−1494.
- Hertog, M.G.L. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study / M.G.L. Hertog, E.J.M. Feskens, P.C.H. Hollman et al.// Lancet. 1993.-Vol.342.-P. 1007−1011.
- High-glucose-altered endothelial cell function involves both disruption of cell-to-cell connection and enhancement of force development / R. Nobe, M. Miyatake, T. Sone, K. Honda. // J. Pharmacol. Exp. Ther. 2006. — Vol. 318. -P. 530−539.
- Hodgson, J.M. Regular ingestion of black tea improves brachial artery vasodilator function / J.M. Hodgson, I.B. Puddey, V. Burke et al. // Clin. Sci. (Lond). 2002. — Vol.102. — P. 195−201.
- Hornig, B. Bradykinin in human endothelial dysfunction / B. Hornig // Drugs. 1997. — Vol. 54, N 5. — P. 42−47.
- Hypercholesterolemia enhances thromboembolism in arterioles but not venules: complete reversal by L-arginine / M.A.Broeders, G.J. Tangelder, D.W. Slaaf et al. // Arterioscler. Thromb. Vase. Biol. 2002. — Vol. 22. — P. 680−685.
- Identification of protein disulfide isomerase as an endothelial hypoxic.stress.protein / K.K.Graven, C. Molvar, J.S. Roncaratietal. // AmJ. Physiol.1.ng. Cell. Mol. Physiol. 2002. — Vol. 282. — P. 996−1003.
- Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine de-iminases / J.M. Leiper, J. Santa Maria, A. Chubb et al. // Biochem. J. 1999. -Vol. 343.-P. 209—214.
- Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine dimethylaminohydrolase / R.Y. Lin, A. Ito, T. Asagami et.al. // Circulation. 2002. — Vol. 106. — P. 987−992.
- Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure / M. Usui, H. Matsuoka, H. Miyazaki et al. // Life Sci.- 1998. Vol. 62. — P. 2425−2430.
- Inducible nitric-oxide synthase generates superoxide from the reductase domain / Y. Xia, LJ. Roman, B.S.S. Masters, J.L. Zweier // J. Biol. Chem. -1998. Vol 273. — P. 22 635−22 639.
- Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats / V.W. Nunes, Z.B. Fortes, D. Nigro et al. // Gen. Pharmacol.- 2000. Vol. 34(2). — P. 117−125.
- Influence of peroxynitrite on energy metabolism and cardiac function in a rat ischemia-reperfiision model / W. H. Lee, J. S. Gounarides, E. S. Roos, M.
- S. Wolin // Am. J. Physiol. Heart Circ. Physiol. 2003. — Vol. 285. — P. 1385 -1395
- Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells / X. Du, T. Matsumura, D. Edelstein et al. // J. Clin. Invest. 2003. — Vol. 112. — P. 10 491 057.
- Involvement of human PEC AM-1 in angiogenesis and in vitro endothelial cell migration / G. Cao, C. D. O’Brien, Z. Zhou et al. // Am. J. Physiol. Cell. Physiol. 2002. — Vol. 282. — P. l 181 — 1190.
- Ischemic Preconditioning Phosphorylates Mitogen-activated Kinases and Heat Shock Protein 27 in the Diabetic Rat Heart / D. Ebel, O. Torna, S. Appier et all // Horm. Metab. Res. 2009. — № 41.- P. 10−15.
- Keli, S.O. Dietary flavanoids, antioxidant vitamins, and incidence of stroke: the Zutphen study / O.S. Keli, M.G.L. Hertog, E.J.M. et al. // Arch. Intern. Med. 1996. — Vol.156. — P.637−642.
- Knekt, P. Flavonoid intake and coronary mortality in Finland: a cohort study / P. Knekt, R. Jarvinen, A. Reunanen et al. // J. BMJ. 1996. — Vol.312. -P.478−481.
- L-arginine normalizes coronary vasomotion in long-term smokers / R. Campisi, J. Czernin, R.F. Schoder R.F. et al. // Circulation. 1999. — Vol. 99. P. 491−497.
- Laursen, J.B. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension / J. B .Laursen, S. Rajagopalan, Z. Galis // Circulation. 1997. — Vol. 95. — P. 588−593.
- Lin, K.Y. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine dimethylaminohydrolase / K.Y. Lin, A. Ito, T. Asagami et.al. // Circulation. 2002. — Vol. — 106. — P. 987−992.
- Luscher, T.F. Endothelial control of vascular tone and growth / T. F1.scher // Clin. Exp. Hypertens. 1990. — Vol. 12. — P. 897−902.
- Luscher, T.F. Endothelium derived vasoactive factors and regulation of vascular tone in human blood vessels / T. F Luscher // Lung. — Vol.168. — 1990. — P. 27−34:
- Luscher, T.F. The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator / T.F. Luscher, G. Noll // Atherosclerosis.-1995.-.Vol. 118. P. 81−90.
- Marin, J. Role of vascular nitric oxide in physiological and pathological conditions / J. Marin, M.A. Rodriguez-Martinez // Pharmacol. Ther. 1997. -Vol., 76.-P. 111−134.
- Marked increase of asymmetric dimethylarginine in patients ' with incipient primary chronic- renal disease / J.T. Kielstein, R.H. Boger, S.M. Bode-Boger et al. // J. Am. Soc. Nephrol. 2002. — Vol. 13. — P. 170−176. •
- Maxwell, A.J. Cardiovascular effects of L-arginine / A.J. Maxwell, J.P. Cooke // Curr. Opin. Nephrol. Hypertens. 1998. — Vol. 7. — P. 63−70.
- Mechanism of superoxide generation by neuronal nitric-oxide synthase / S. Pou, L. Keaton, W. Surichamorn, G.M. Rosen // J. Biol. Chem. 1999. -Vol.274.-P. 9573−9580-
- Membrane stabilization in harvested vein graft storage: effects on adhesion molecule expression and nitric oxide synthesis / K. Mf Vural^ M.C. Oz, H. Liao et al. // Eur. J. Cardiothorac. Surg. 1999. — Vol. 16. — P. 150−155.
- Metabolism of methylarginines by human vasculature- implication for the regulation of nitric oxide synthesis / R. J. MacAllister, S.A. Fikling, G.S. Whilley et al. // Br. J. Pharmacol. 1994. — Vol. 112. — P. 43— 48.
- Michel, T. Nitric oxide synthases: which, where, how and why / T. Michel, O. Feron // J. Clin. Invest. 1997. — Vol. 100. — P. 2146−2152.
- Miyazaki, H. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis / H. Miyazaki, H. Matsuoka, J.P. Cooke et al. // Circulation. 1999. — Vol. 99. — P. 1141−1146.
- Molecularplasticity of vascular wall during N (G) — nitro-L-arginine-methyl ester- induced hypertension: modulation of proinflammatory signals / W. Ganzales, V. Fontaine, M.E. Pueyo et al. // Hypertension.— 2000.— Vol. 36.—P. 103—109.
- Moncada, S. Molecular mechanisms and therapeutic strategies related to. nitric oxide / S. Moncada, E.A. Higgs // FASEB J. 1995. — Vol. 9. — P. 13 191 330.
- Mukamal, K.J. Tea consumption and mortality after acute myocardial infarction / K.J. Mukamal, M. Maclure, J.E. Muller et al. // Circulation. -2002. Vol. 105.- P.2476−2481.
- NAD (P)H oxidase inhibition improves endothelial function in rat and human blood vessels / C.A. Hamilton, M.J."Brosnan, S. A1-Benna et. al. // Hypertension. 2002. Vol. 40. — P. 755−762.
- Niebauer, J. NOS inhibition accelerates atherogenesis: reversal by exercise / J. Niebauer, A.J. Maxwell, P. S. Lin //. Am. J. Physiol. Heart. Circ. Physiol. -2003.-Vol. 285. P. 535−540.
- Nilsson, I. Differential activation of vascular genes by hypoxia in primary endothelial cells / I. Nilsson, M. Shibuya, S. Wennstrom //.Exp. Cell. Res. 2004. — Vol. 299. — P. — 476−485.
- Nitric oxide as a signaling molecule in the vascular system: an overview / L.J. Ignarro, G. Clrino, A. Casini, C. Napoli // J. Cardiolvasc. Pharmacol. -1999.-Vol. 34. — P.879−886.
- Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol / V.B. O’Donnell, P.H. Chumley, N. Hogg et al. // Biochemistry. 1997. — Vol. 36. — P. 1 521 615 223.
- Nitric oxide/cGMP protects endothelial cells from hypoxia-mediated leakiness / G.K. Kolluru, K.P. Tamilarasan, A.S. Rajkumar et al. // Eur. J. Cell. Biol.-2008.-Vol. 87. — P. 147−161.
- Opening of mitochondrial KATP channel occurs downstream of PKC-epsilon activation in the mechanism of preconditioning / Y. Ohnuma, T. Miura, T. Miki, et al. // Am. J. Physiol. Heart. 2002. Vol. 283. — P. 440 — 447.
- O’Reilly JD, Mallet AI, McAnlis GT, et al. Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Am J Clin Nutr 2001−73:1040−4.
- Pacher, P. Nitric oxide and peroxynitrite in health and disease / P. Pacher, J.S. Beckman, L. Liaudet // Physiol. Rev., — 2007. Vol 87. — P. 315 424.
- Palmer, R.M.J. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor / R.M.J. Palmer, A.G. Ferringe, S. Moneada // Nature. 1987. — Vol. 327. — P. 524 — 526.
- Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 2001−154:495−503.
- Physiology and biochemistry of endothelial function in children with chronic renal failure / J.A. Kan, A.T. Donald, D.T. Vallance el al. // Kidney Intern. -1997. Vol. 52. — P. 468-^72.
- Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase is elevated in hyperthyroid patients / C. Hermenegildo, P. Medina, M. Peiro et al. // J. Clin. Endocrinol. Metab. 2002. -Vol. 87. P. 5636−5640.
- Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study / C. Zoccali, S. Bode-Boger, F. Mallamaci et al. //Lancet. -2001. Vol. 358. — P. 2113−2117.
- Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia / D.P.
- Holden, S.A. Fickling, G. Whitley, S.S. Nussey // Am. J. Obstet. Gynecol. -1998,—Vol.-178.-P. 551−556.
- Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation / M.D. Linden, P. Whittaker, A.L. Frelinger et al. // J. Thromb. Haemost. 2006. — Vol. 4. — P. 2670−2677.
- Prevention of atrial fibrillation following cardiac surgery: basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning / R. Rodrigo, M. Cereceda, R. Castillo et al. //. Pharmacol. Ther. 2008. -Vol. 118.-P. 104−127.
- Protein tyrosine kinase signaling is necessary for NO donor-induced late preconditioning against myocardial stunning / X.L.Tang, E. Kodani, H. Takano et al. // Am. J. Physiol. Heart. 2003. — Vol. 284. — P. 1441−1448.
- Pyner, S. The role of free radicals in the muscle vasodilatation of systemic hypoxia in the rat / S. Pyner, A. Coney, J.M. Marshall. // Exp. Physiol. 2003. -Vol. 88. — P. 733−740.
- Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase / S. Ueda, S. Kato, H. Matsuoka et al. // Circ. Res. 2003. — Vol. 92. — P. 226−233.
- Regulation of P-selectin expression in human endothelial cells by nitric oxide / V.E. Armstead, A.G. Minchenko, R.A. Schuhl et al. // Am. J. Physiol. -1997. Vol. 273. — P. 740−746.
- Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor / M.C. Stuhlinger, F. Abbasi, J.W. Chu et al. // JAMA. -2002. Vol. 287. — P. 1420−1426.
- Renin-angiotensin system blockade improves endothelial dysfunction in hypertension / K. Goto, K. Fujii, U. Onaka et al. // Hypertension. 2000. -Vol. 36, N4.-P. 575−580.
- Rimm, E.B. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals / E.B. Rimm, M.B. Katan, A. Ascherio et al. // Ann. Intern. Med. 1996. — Vol. 125. — P.384−389.
- Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine / V.P. Valkonen, H. Paiva, J.T. Salonen et al. // Lancet. -2001. -Vol. 358. P. 2127−2128.
- Rubanyi, G.M. Effect of Cilazapril and indomethacin on endothelial dysfunction in the aortas of spontaneously hypertensive rats / G.M. Rubanyi, K. Kauser, T.J. Gruser // Cardiovasc Pharmacol. 1993. — Vol. 22(suppl. 5). -P 23−30.
- Schiffrin, E. L A critical review of the role of endothelial factors in the pathogenesis of hypertension / E. L Schiffrin // J. Cardiovasc. Pharmacol. -2001.-Vol. 38.-P. 3−6.
- Schroeter, H. (—)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans / H. Schroeter, C. Heiss, J. Balzer et al. //. Proc. Natl. Acad. Sei. U. S. A. 2006.-Vol.103.-P.1024−1029. .
- Sesso, H.D. Coffee and tea intake and the risk of myocardial infarction / H.D. Sesso, J.M. Gaziano, J.F. Buring et al. //. Am. J. Epidemiol. 1999. -Vol.149.-P.162−167.
- Sesso, H.D. Flavonoid intake and the risk of cardiovascular disease in women / H.D. Sesso, J.M. Gaziano, J.F. Buring et al. // Am. J. Clin. Nutr. -2003. Vol.77. — P. 1400−1408.
- Sesso, H.D. Lack of association between tea and cardiovascular disease ---in college alumni / H.D. Sesso, R.S. Jr. Paffenbarger, Y. Oguma et al. // Int. J.
- Epidemiol. 2003. — Vol.32. — P.527−533.
- Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake / N. Fujiwara, T. Osanai, T. Kamada et al. / Circulation. — 2000. Vol. 101.-P. 856−861.
- Stuehr, D. J. Mammalian nitric oxide synthases / D.J. Stuehr, // Biochem. Biophys. Acta. 1999. — Vol. 1411. — P. 217−230.
- Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors / J. Vasquez-Vivar, B. Kalyanaraman, R. Martasek et al. // Proc. Nat. Acad. Sci. USA. 1998. — Vol. 95. — P. 9220−9225.
- Superoxide generation from endothelial nitric-oxide synthase / Y. Xia, A-L. Tsai, V. Berka, J.L. Zweier // J. Biol. Chem. 1998. — Vol. 273. -P.25 804−25 808.
- Taniyama, Y. Reactive oxygen species in the vasculature: molecular and cellular mechanisms / Y. Taniyama, K.K. Griendling // Hypertension. 2003. -Vol. 42.-P. 1075—1081.
- The angiotensin II receptors / M. De. Gasparo, K.J. Catt, T. Inagami et al. // International Union of Pharmacology. XXIII. Pharmacol Rev. 2000. -Vol. 52. P. 415−472.
- The vascular effects of L-Arginine in humans. The role of endogenous insulin. / D. Giugliano, R. Marfella, G. Verazzo et al. // J. Clin. Invest. 1997. -Vol.99. P. 433−438.
- Thompson, L. P. Chronic hypoxia decreases endothelial nitric oxide synthease protein expression in" fetal guinea pig / L. P. Thompson, Y. Dong7/ Hearts Reproductive Sciences. 2005. — Vol. 12. — P. 388 — 395.
- Tschudi, M.R. Nitric oxide: the endogenous nitrate in the cardiovascular system / M.R. Tschudi, T.F. Luscher // Herz. 1996. — Vol.21. — P. 50−60.
- Vanhoutte P.M. Endothelial dysfunction and atherosclerosis / P.M. Vanhoutte // Eur. Heart. J. 1997. — Vol. 18. — P. 19−29.
- Vascular endothelial growth factor gene expression regulated by protein kinase C pathway in endothelial cells during hypoxia / Z. Zhou, X.M. Yang, Y.Z. Xie, Z.Y. Yin // Space Med .Eng. (Beijing). 2002. — Vol. 15. — P. 322 326.
- Vasoactive systems in. L-NAME hypertension: the role of inducible nitric oxide synthase / O. Pechanova, Z. Dobesova, J. Cejka et al. // J. Hypertens. — 2004.-Vol. 22, № 1.-P. 167−173.
- Veirma, S. Fundamentals of endothelial function for the clinical cardiologist / S. Verma, T. J Anderson // Circulation. 2002. — Vol. 105. — P. 546−549.
- Wakefield, T. W. Mechanisms of Venous Thrombosis and Resolution / T. W. Wakefield, D. D. Myers, P. K. Henke // Arterioscler. Thromb. Vase. Biol. 2008. — Vol. 28. — P. 3 87 — 391.
- Walsh, M. P. The early effects of chronic hypoxia on the cardiovascular «» system in the rat: role of nitric oxide / Mr P. Walsh, J. M. Marshall //J.
- Physiol. 2006. — Vol. 575. — P. 263 — 275.
- Widlansky, M. E. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease / M.E. Widlansky, N.M. Hamburg, E. Anteret al. // J. Am. Coll. Nutr. 2007. — Vol.26. — P.95−101.
- Woodman, O.L. 3', 4'-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta / O.L.Woodman, W. Malakul / Life Sci.-2009. Jul. 3. — Vol.85(l-2). — P.54−59.
- Xiao, H.B. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women / H.B. Xiao, Jun-Fang, X.Y. Lu et al. // Am. J. Epidemiol. 1999. — Vol.149. -P.943−949.
- Yosef-Levi, I.M. C-reactive protein and atherothrombosis-a prognostic factor or a risk factor? / I.M. Yosef-Levi, E. Grad, H.D. Danenberg // Harefuah. 2007. — Vol. 146. — P. 970−974.
- Zhou, J. Ventricular remodeling by Scutellarein treatment in spontaneously hypertensive rats / J. Zhou, H. Lei, Y. Chen et al. // Chin. Med. J. (Engl). 2002. — Vol. 115, N 3. — P. 375−377.
- Zhu, B.H. Effects of Scutellarein on diabetic rat aorta / B.H. Zhu, Y.Y.Guan, M.J. He H, Lin // Acta Pharmacol. Sin. 2000. — Apr.21(4). P.353−356.